
Close on the heels of an M&A deal, GlaxoSmithKline plc (NYSE:GSK) confirmed the spin-off of the consumer healthcare business it jointly owns with U.S. pharma giant Pfizer, Inc. (NYSE:PFE).
What Happened: GSK said it is spinning off its consumer healthcare business into an independently-traded public company, named Haleon, a regulatory filing on Wednesday showed.